Department of Pharmaco-Biology and Cell Biology, University of Calabria, Arcavacata di Rende (CS) 87036, Italy.
J Cell Sci. 2010 Nov 15;123(Pt 22):3956-65. doi: 10.1242/jcs.055806. Epub 2010 Oct 27.
Steroid production in the adrenal zona glomerulosa is under the control of angiotensin II (Ang II), which, upon binding to its receptor, activates protein kinase C (PKC) within these cells. PKC is a potent inhibitor of the steroidogenic enzyme CYP17. We have demonstrated that, in the ovary, PKC activates expression of FOS, a member of the AP-1 family, and increased expression of this gene is linked to CYP17 downregulation. However, the pathway and the molecular mechanism responsible for the inhibitory effect of PKC on CYP17 expression are not defined. Herein, we demonstrated that Ang II inhibited CYP17 through PKC and ERK1/2-activated FOS and that blocking FOS expression decreased PKC-mediated inhibition. Although CYP17 transcription was activated by the nuclear receptor SF-1, expression of FOS resulted in a decrease in SF-1-mediated gene transcription. FOS physically interacted with the hinge region of SF-1 and modulated its transactivity, thus preventing binding of cofactors such as SRC1 and CBP, which were necessary to fully activate CYP17 transcription. Collectively, these results indicate a new regulatory mechanism for SF-1 transcriptional activity that might influence adrenal zone-specific expression of CYP17, a mechanism that can potentially be applied to other steroidogenic tissues.
肾上腺球状带的类固醇生成受血管紧张素 II(Ang II)的控制,Ang II 与受体结合后,在这些细胞内激活蛋白激酶 C(PKC)。PKC 是一种有效的甾体生成酶 CYP17 的抑制剂。我们已经证明,在卵巢中,PKC 激活了 FOS 的表达,FOS 是 AP-1 家族的一员,这种基因的表达增加与 CYP17 的下调有关。然而,PKC 对 CYP17 表达的抑制作用的途径和分子机制尚不清楚。在此,我们证明 Ang II 通过 PKC 和 ERK1/2 激活的 FOS 抑制 CYP17,并且阻断 FOS 表达可降低 PKC 介导的抑制作用。尽管 CYP17 的转录被核受体 SF-1 激活,但 FOS 的表达导致 SF-1 介导的基因转录减少。FOS 与 SF-1 的铰链区相互作用,并调节其转录活性,从而阻止了如 SRC1 和 CBP 等辅助因子的结合,这些因子对于完全激活 CYP17 转录是必需的。总之,这些结果表明了 SF-1 转录活性的一种新的调节机制,它可能影响 CYP17 在肾上腺带的特异性表达,这一机制可能适用于其他甾体生成组织。